GSH is a known radical scavenger that decreases the number of free radicals available to sustain the polymerization cycle [11]
Semaglutide has a longer track record, a cardiovascular benefit proven in the SELECT trial, and now an oral formulation (Wegovy pill)
Trials with older GLP-1 drugs (liraglutide, exenatide) including the large ADJUNCT ONE and ADJUNCT TWO studies showed modest HbA1c improvements of 0.10.7%, meaningful weight loss, and lower insulin requirements, but also raised early concerns about hypoglycemia and ketosis that kept enthusiasm in check for years
To view or add a comment, sign in Obesity care is entering a new era and Withings Health Solutions is leading the way
Phosphodiesterase 10A inhibition improves cortico-basal ganglia function in Huntingtons disease models
In some embodiments, the otic formulation or composition comprises about 6% by weight of the silicon dioxide